Kailera Therapeutics, Inc. (KLRA) SEC filings
KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)
Close on Nov 17, 2026Market cap $1.58BP/E –Yield –
SEC filings
7 of Kailera Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 4, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2026 | Nov 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 20, 2026 | SEC EDGAR |
See a number that looks wrong?